Empfohlene Literatur (HHT Morbus Osler)

Autor/en

Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff UW, McDonald J, Proctor DD, et al. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. Journal of medical genetics. 2011 Feb;48(2):73-87. PubMed PMID: 19553198.

Govani FS, Shovlin CL. Hereditary haemorrhagic telangiectasia: a clinical and scientific review. European journal of human genetics : EJHG. 2009 Jul;17(7):860-71. PubMed PMID: 19337313. Pubmed Central PMCID: 2986493.

Verkerk MM, Shovlin CL, Lund VJ. Silent threat? A retrospective study of screening practices for pulmonary arteriovenous malformations in patients with hereditary haemorrhagic telangiectasia. Rhinology. 2012 Sep;50(3):277-83. PubMed PMID: 22888484.

Moulinet T, Mohamed S, Deibener-Kaminsky J, Jankowski R, Kaminsky P. High prevalence of arterial aneurysms in hereditary hemorrhagic telangiectasia. International journal of cardiology. 2014 Oct 20;176(3):1414-6. PubMed PMID: 25150474.

Donaldson JW, McKeever TM, Hall IP, Hubbard RB, Fogarty AW. Complications and mortality in hereditary hemorrhagic telangiectasia: A population-based study. Neurology. 2015 May 05;84(18):1886-93. PubMed PMID: 25862798. Pubmed Central PMCID: 4433463.

Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). American journal of medical genetics. 2000 Mar 06;91(1):66-7. PubMed PMID: 10751092.

Geirdal AO, Dheyauldeen S, Bachmann-Harildstad G, Heimdal K. Quality of life in patients with hereditary hemorrhagic telangiectasia in Norway: a population based study. American journal of medical genetics Part A. 2012 Jun;158A(6):1269-78. PubMed PMID: 22529055.

Lund VJ, Howard DJ. A treatment algorithm for the management of epistaxis in hereditary hemorrhagic telangiectasia. AmJRhinol. 1999 7/1999;13(4):319-22.

Wirsching KE, Kuhnel TS. Update on Clinical Strategies in Hereditary Hemorrhagic Telangiectasia From an ENT Point of View. Clinical and experimental otorhinolaryngology. 2016 Jul 21. PubMed PMID: 27440131.

Lund VJ, Howard DJ. Closure of the nasal cavities in the treatment of refractory hereditary haemorrhagic teleangiectasia. The Journal of Laryngology and Otology. 1996 1996;111:30-3.

van Gent MW, Post MC, Snijder RJ, Westermann CJ, Plokker HW, Mager JJ. Real prevalence of pulmonary right-to-left shunt according to genotype in patients with hereditary hemorrhagic telangiectasia: a transthoracic contrast echocardiography study. Chest. 2010 Oct;138(4):833-9. PubMed PMID: 20154077.

Faughnan ME, Granton JT, Young LH. The pulmonary vascular complications of hereditary haemorrhagic telangiectasia. Eur Respir J. 2009 May;33(5):1186-94. PubMed PMID: 19407052.

Gallitelli M, Lepore V, Pasculli G, Di GL, Logroscino G, Carella A, et al. Brain abscess: a need to screen for pulmonary arteriovenous malformations. Neuroepidemiology. 2005 2005;24(1-2):76-8.

Chavan A, Caselitz M, Gratz KF, Lotz J, Kirchhoff T, Piso P, et al. Hepatic artery embolization for treatment of patients with hereditary hemorrhagic telangiectasia and symptomatic hepatic vascular malformations. European radiology. 2004 Nov;14(11):2079-85. PubMed PMID: 15316741.

Chavan A, Schumann-Binarsch S, Luthe L, Nickau B, Elsasser A, Kuhnel T, et al. Systemic therapy with bevacizumab in patients with hereditary hemorrhagic telangiectasia (HHT). VASA Zeitschrift fur Gefasskrankheiten. 2013 Mar;42(2):106-10. PubMed PMID: 23485837.

Willemse RB, Mager JJ, Westermann CJ, Overtoom TT, Mauser H, Wolbers JG. Bleeding risk of cerebrovascular malformations in hereditary hemorrhagic telangiectasia. J Neurosurg. 2000 May;92(5):779-84. PubMed PMID: 10794291.

de Gussem EM, Lausman AY, Beder AJ, Edwards CP, Blanker MH, Terbrugge KG, et al. Outcomes of pregnancy in women with hereditary hemorrhagic telangiectasia. Obstetrics and gynecology. 2014 Mar;123(3):514-20. PubMed PMID: 24499751.

Dupuis-Girod S, Giraud S, Decullier E, Lesca G, Cottin V, Faure F, et al. Hemorrhagic hereditary telangiectasia (Rendu-Osler disease) and infectious diseases: an underestimated association. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2007 Mar 15;44(6):841-5. PubMed PMID: 17304458.

Geisthoff UW et al. How to manage patients with hereditary hemorrhagic telangiectasia. Br J Haematol 2015; 171(4): 443- 52.

Marziniak M, Jung A, Guralnik V, Evers S, Prudlo J, Geisthoff UW. An association of migraine with hereditary haemorrhagic telangiectasia independently of pulmonary right-to-left shunts . Cephalalgia : an international journal of headache. 2009 Jan;29(1):76-81. PubMed PMID: 18771488.

Rohrmeier C, Sachs HG, Kuehnel TS. A retrospective analysis of low dose, intranasal injected bevacizumab (Avastin) in hereditary haemorrhagic telangiectasia. Eur Arch Otorhinolaryngol. 2012 Feb;269(2):531-6. PubMed PMID: 21805356.